Skip to main content
PMVP
NASDAQ Life Sciences

PMV Pharma Posts $34.4M Q3 Loss as Cash Runway Tightens

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.26
Mkt Cap
$94.391M
52W Low
$1.02
52W High
$1.91
52W Position info
23% above low
Off High info
34% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

PMVP sits 23% above its 52-week low of $1.02 on light trading volume (0.3× avg).

Summary

PMV Pharmaceuticals reported a $34.4 million third-quarter loss, a sharp widening from the $18.09 million net loss it posted in Q2, with the loss per share at 52 cents and research and development expenses of $16.1 million. The company entered the quarter with a going-concern warning and a $79.4 million cash balance as of the June 30 10-Q, so a loss of this size consumes a large share of remaining liquidity; it reported $108.5 million in cash and $52.4 million in nine-month operating cash use. It follows the $50.8 million offering priced September 1 at $1.21 per share with warrants, which was already a steep discount to the prior price. With the stock at $1.26 and a micro-cap valuation, dilution risk and runway are the dominant issues for holders.

At the time of this announcement, PMVP was trading at $1.26 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $94.4M. The 52-week trading range was $1.02 to $1.91. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

PMVP - Latest Insights

PMVP
Nov 10, 2026, 8:02 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.25
Real-time Price: $1.22 info
Change: -$0.030 (-2%) info
Market Cap: $92.126M info
PMVP
Sep 01, 2026, 6:23 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.27
Real-time Price: $1.22 info
Change: -$0.050 (-4%) info
Market Cap: $92.126M info
PMVP
Sep 01, 2026, 6:01 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $1.27
Real-time Price: $1.22 info
Change: -$0.050 (-4%) info
Market Cap: $92.126M info
PMVP
Aug 31, 2026, 11:03 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.19
Real-time Price: $1.22 info
Change: +$0.030 (+3%) info
Market Cap: $92.126M info
PMVP
Aug 31, 2026, 4:25 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $1.05
Real-time Price: $1.22 info
Change: +$0.170 (+16%) info
Market Cap: $92.126M info